Casdin Capital, LLC Tenaya Therapeutics, Inc. Transaction History
Casdin Capital, LLC
- $855 Million
- Q1 2025
A detailed history of Casdin Capital, LLC transactions in Tenaya Therapeutics, Inc. stock. As of the latest transaction made, Casdin Capital, LLC holds 6,732,971 shares of TNYA stock, worth $3.16 Million. This represents 0.45% of its overall portfolio holdings.
Number of Shares
6,732,971
Previous 6,732,971
-0.0%
Holding current value
$3.16 Million
Previous $9.63 Million
60.15%
% of portfolio
0.45%
Previous 0.83%
Shares
4 transactions
Others Institutions Holding TNYA
# of Institutions
105Shares Held
48.5MCall Options Held
74.4KPut Options Held
78.4K-
Column Group LLC San Francisco, CA9.4MShares$4.42 Million12.12% of portfolio
-
Woodline Partners LP San Francisco, CA5.92MShares$2.78 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.08MShares$1.92 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.07MShares$1.91 Million0.0% of portfolio
-
Jpmorgan Chase & CO New York, NY2.26MShares$1.06 Million0.0% of portfolio
About Tenaya Therapeutics, Inc.
- Ticker TNYA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,364,700
- Market Cap $19.4M
- Description
- Tenaya Therapeutics, Inc., a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. It develops its products through cellular regeneration, gene therapy, and precision medicine platforms. The company is developing TN-201, an adeno-associated virus (AAV)-based gene therapy to address genetic hyp...